Report cover image

Hospital Acquired Infection Control Market by Type (Diagnostic & Testing Equipment, Disinfection Products, Hand Hygiene Products), Indication (Bloodstream Infections, Clostridioides difficile Infections, Hospital-acquired Pneumonia), End-user - Global For

Publisher 360iResearch
Published Apr 17, 2024
Length 194 Pages
SKU # IRE18713058

Description

Hospital Acquired Infection Control Market by Type (Diagnostic & Testing Equipment, Disinfection Products, Hand Hygiene Products), Indication (Bloodstream Infections, Clostridioides difficile Infections, Hospital-acquired Pneumonia), End-user - Global Forecast 2024-2030


The Hospital Acquired Infection Control Market size was estimated at USD 34.26 billion in 2023 and expected to reach USD 36.39 billion in 2024, at a CAGR 6.48% to reach USD 53.20 billion by 2030.

Hospital acquired infection (HAI) control refers to the systematic approach and dedicated efforts undertaken by healthcare institutions to prevent and manage infections acquired by patients during their stay in hospitals & other healthcare facilities. These infections can occur as a result of exposure to various microbial agents, including bacteria, viruses, fungi, and other pathogens. The control measures span a wide range of strategies, including rigorous hygiene practices, sterilization and disinfection procedures, use of personal protective equipment (PPE), surveillance of infections, and adherence to protocols for invasive procedures and antibiotic stewardship. The rising awareness about infections acquired in healthcare settings, coupled with a rapidly growing emphasis on infection control policies, boosts the market growth. However, high costs associated with advanced infection control technologies can be prohibitive for resource-limited settings. Furthermore, technological advancements in sterilization and disinfection processes, along with the development of eco-friendly and more efficient disinfectants, pose significant opportunities to the manufacturers.



Please Note: PDF & Excel + Online Access - 1 Year

Table of Contents

194 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
5.1.1.2. Growing prevalence of chronic diseases with increasing geriatric population
5.1.1.3. Increasing use of disinfectants and medical nonwovens in the healthcare industry
5.1.2. Restraints
5.1.2.1. High cost associated with the endoscope reprocessors and microbial testing instruments
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
5.1.3.2. Technological advancements in sterilization & disinfection processes and infection control devices
5.1.4. Challenges
5.1.4.1. Concerns associated with the safety of reprocessed instruments
5.2. Market Segmentation Analysis
5.2.1. Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
5.2.2. End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Hospital Acquired Infection Control Market, by Type
6.1. Introduction
6.2. Diagnostic & Testing Equipment
6.3. Disinfection Products
6.4. Hand Hygiene Products
6.5. Personal Protective Equipment
6.6. Sterilization Equipment
7. Hospital Acquired Infection Control Market, by Indication
7.1. Introduction
7.2. Bloodstream Infections
7.3. Clostridioides difficile Infections
7.4. Hospital-acquired Pneumonia
7.5. Multidrug-Resistant Organisms
7.6. Surgical Site Infections
7.7. Urinary Tract Infections
8. Hospital Acquired Infection Control Market, by End-user
8.1. Introduction
8.2. Ambulatory Surgical & Diagnostic Centers
8.3. Hospitals & ICUs
8.4. Nursing Homes & Maternity Centers
9. Americas Hospital Acquired Infection Control Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hospital Acquired Infection Control Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hospital Acquired Infection Control Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap
12.3.2. PAMA introduces new ethylene oxide sterilisation solution
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us